

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.94852743 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.90915366 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.90915366 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.70667947 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.36286811 |
| 6 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.04341950 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.71252168 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 4.71252168 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.71252168 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.71252168 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.71252168 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 4.71252168 |
| 13 | positive regulation of B cell differentiation (GO:0045579) | 4.62741049 |
| 14 | detection of other organism (GO:0098543) | 4.45145647 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.40885127 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.33018188 |
| 17 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.31261230 |
| 18 | B cell receptor signaling pathway (GO:0050853) | 4.30706200 |
| 19 | detection of bacterium (GO:0016045) | 4.30066572 |
| 20 | leukocyte aggregation (GO:0070486) | 4.25034053 |
| 21 | regulation of B cell differentiation (GO:0045577) | 4.23801350 |
| 22 | regulation of gamma-delta T cell activation (GO:0046643) | 4.19330664 |
| 23 | immunoglobulin mediated immune response (GO:0016064) | 4.16631016 |
| 24 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.02710802 |
| 25 | negative regulation of cell killing (GO:0031342) | 3.88489448 |
| 26 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.88489448 |
| 27 | negative regulation of T cell mediated immunity (GO:0002710) | 3.83393207 |
| 28 | detection of external biotic stimulus (GO:0098581) | 3.79852394 |
| 29 | neutrophil activation involved in immune response (GO:0002283) | 3.79556018 |
| 30 | respiratory burst (GO:0045730) | 3.79088947 |
| 31 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.75994287 |
| 32 | positive regulation of interferon-alpha production (GO:0032727) | 3.71182988 |
| 33 | response to peptidoglycan (GO:0032494) | 3.69386646 |
| 34 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.68825787 |
| 35 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.64433095 |
| 36 | regulation of interferon-alpha production (GO:0032647) | 3.58536841 |
| 37 | detection of molecule of bacterial origin (GO:0032490) | 3.57839949 |
| 38 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.52664650 |
| 39 | microglial cell activation (GO:0001774) | 3.52207522 |
| 40 | macrophage activation involved in immune response (GO:0002281) | 3.51926530 |
| 41 | positive regulation of antigen processing and presentation (GO:0002579) | 3.50212407 |
| 42 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.50208066 |
| 43 | regulation of T cell tolerance induction (GO:0002664) | 3.47739700 |
| 44 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.47665741 |
| 45 | cellular extravasation (GO:0045123) | 3.46403357 |
| 46 | positive thymic T cell selection (GO:0045059) | 3.45060666 |
| 47 | T cell migration (GO:0072678) | 3.41776444 |
| 48 | tolerance induction (GO:0002507) | 3.38129797 |
| 49 | B cell mediated immunity (GO:0019724) | 3.36794455 |
| 50 | detection of biotic stimulus (GO:0009595) | 3.34718374 |
| 51 | negative thymic T cell selection (GO:0045060) | 3.34570147 |
| 52 | regulation of tolerance induction (GO:0002643) | 3.34010176 |
| 53 | response to type I interferon (GO:0034340) | 3.33425976 |
| 54 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.32517336 |
| 55 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.31249074 |
| 56 | cellular response to type I interferon (GO:0071357) | 3.30369711 |
| 57 | type I interferon signaling pathway (GO:0060337) | 3.30369711 |
| 58 | negative T cell selection (GO:0043383) | 3.30130766 |
| 59 | defense response to protozoan (GO:0042832) | 3.29134650 |
| 60 | negative regulation of phagocytosis (GO:0050765) | 3.26911242 |
| 61 | response to interleukin-15 (GO:0070672) | 3.23033109 |
| 62 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.22953166 |
| 63 | response to protozoan (GO:0001562) | 3.22263240 |
| 64 | negative regulation of interleukin-12 production (GO:0032695) | 3.20757875 |
| 65 | macrophage activation (GO:0042116) | 3.20574480 |
| 66 | positive regulation of mast cell activation (GO:0033005) | 3.19820053 |
| 67 | myeloid dendritic cell activation (GO:0001773) | 3.19365346 |
| 68 | mature B cell differentiation (GO:0002335) | 3.19136520 |
| 69 | response to muramyl dipeptide (GO:0032495) | 3.19040167 |
| 70 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.18306832 |
| 71 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.17723322 |
| 72 | response to host immune response (GO:0052572) | 3.17723322 |
| 73 | myeloid cell activation involved in immune response (GO:0002275) | 3.16086573 |
| 74 | neutrophil activation (GO:0042119) | 3.15304841 |
| 75 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.13943041 |
| 76 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.13857670 |
| 77 | mast cell activation (GO:0045576) | 3.12123100 |
| 78 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.09177039 |
| 79 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.09177039 |
| 80 | neutrophil mediated immunity (GO:0002446) | 3.09088631 |
| 81 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.08039781 |
| 82 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.07692308 |
| 83 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.06246586 |
| 84 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.05755660 |
| 85 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.05567236 |
| 86 | regulation of regulatory T cell differentiation (GO:0045589) | 3.04971381 |
| 87 | leukocyte degranulation (GO:0043299) | 3.04686855 |
| 88 | NIK/NF-kappaB signaling (GO:0038061) | 3.03575402 |
| 89 | regulation of mast cell activation (GO:0033003) | 3.01613837 |
| 90 | granulocyte activation (GO:0036230) | 3.00672423 |
| 91 | myeloid dendritic cell differentiation (GO:0043011) | 2.99878882 |
| 92 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.98736928 |
| 93 | response to host (GO:0075136) | 2.98543443 |
| 94 | response to host defenses (GO:0052200) | 2.98543443 |
| 95 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.98543443 |
| 96 | leukocyte cell-cell adhesion (GO:0007159) | 2.98434510 |
| 97 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.97193213 |
| 98 | negative regulation of innate immune response (GO:0045824) | 2.96618640 |
| 99 | regulation of antigen processing and presentation (GO:0002577) | 2.96572869 |
| 100 | activated T cell proliferation (GO:0050798) | 2.96233265 |
| 101 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.93321912 |
| 102 | T cell homeostasis (GO:0043029) | 2.93277482 |
| 103 | regulation of leukocyte degranulation (GO:0043300) | 2.91879887 |
| 104 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.88940126 |
| 105 | interferon-gamma production (GO:0032609) | 2.88862111 |
| 106 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.87065216 |
| 107 | thymic T cell selection (GO:0045061) | 2.86634131 |
| 108 | cellular response to zinc ion (GO:0071294) | 2.86618755 |
| 109 | lymphocyte homeostasis (GO:0002260) | 2.83701784 |
| 110 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.83131214 |
| 111 | germinal center formation (GO:0002467) | 2.81645670 |
| 112 | pinocytosis (GO:0006907) | 2.80572775 |
| 113 | cellular response to interleukin-15 (GO:0071350) | 2.80172043 |
| 114 | actin nucleation (GO:0045010) | 2.79869885 |
| 115 | positive regulation of interferon-beta production (GO:0032728) | 2.78494421 |
| 116 | mature B cell differentiation involved in immune response (GO:0002313) | 2.75738232 |
| 117 | T cell selection (GO:0045058) | 2.75556465 |
| 118 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.75457784 |
| 119 | B cell homeostasis (GO:0001782) | 2.75040624 |
| 120 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.70786743 |
| 121 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.69880628 |
| 122 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.68345792 |
| 123 | cellular response to interferon-beta (GO:0035458) | 2.67083712 |
| 124 | positive T cell selection (GO:0043368) | 2.65395398 |
| 125 | negative regulation of B cell proliferation (GO:0030889) | 2.65308886 |
| 126 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.63522257 |
| 127 | positive regulation of interleukin-2 production (GO:0032743) | 2.63480572 |
| 128 | T cell costimulation (GO:0031295) | 2.63437447 |
| 129 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.62801400 |
| 130 | regulation of mast cell degranulation (GO:0043304) | 2.61772051 |
| 131 | regulation of response to interferon-gamma (GO:0060330) | 2.61717459 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.04531945 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.44668106 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.25108329 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.93995859 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.74888423 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.69441410 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.60280870 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.53795127 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.15465148 |
| 10 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.14091715 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.11126059 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 3.10574273 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.03642668 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.86597413 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.84498320 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.83580854 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.81897805 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.70909675 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.57568511 |
| 20 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.49580489 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.46576791 |
| 22 | MYB_26560356_Chip-Seq_TH2_Human | 2.45658754 |
| 23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.45530700 |
| 24 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.44932359 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 2.37372440 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.22900927 |
| 27 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.22282935 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.21541237 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.20638599 |
| 30 | MYB_26560356_Chip-Seq_TH1_Human | 2.14220644 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.13759648 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.13746841 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.10983849 |
| 34 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.10787139 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 2.08723930 |
| 36 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93474842 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.89908139 |
| 38 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.86373939 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.82347052 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73047107 |
| 41 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72572688 |
| 42 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.72018457 |
| 43 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.70467804 |
| 44 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.69881614 |
| 45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.65816600 |
| 46 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64506522 |
| 47 | MAF_26560356_Chip-Seq_TH2_Human | 1.55462444 |
| 48 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.54287987 |
| 49 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.54114445 |
| 50 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.47226389 |
| 51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.46489077 |
| 52 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.46471688 |
| 53 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.44487765 |
| 54 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43853349 |
| 55 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.43166533 |
| 56 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.42626739 |
| 57 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.37137475 |
| 58 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36985311 |
| 59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36140314 |
| 60 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.35600773 |
| 61 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.34787484 |
| 62 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.32416737 |
| 63 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.30314902 |
| 64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28337869 |
| 65 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.25409143 |
| 66 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.24570991 |
| 67 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.23862483 |
| 68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23522451 |
| 69 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21647657 |
| 70 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.21419375 |
| 71 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.20722143 |
| 72 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.19829370 |
| 73 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18745979 |
| 74 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16171927 |
| 75 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.13004230 |
| 76 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12690070 |
| 77 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11041710 |
| 78 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08820947 |
| 79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07651587 |
| 80 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06995918 |
| 81 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06353792 |
| 82 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06324307 |
| 83 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04541553 |
| 84 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03916913 |
| 85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03507954 |
| 86 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01931572 |
| 87 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.00753488 |
| 88 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00574997 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00557653 |
| 90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00439341 |
| 91 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.99952764 |
| 92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98310714 |
| 93 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98188232 |
| 94 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.96643166 |
| 95 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.95625541 |
| 96 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93774969 |
| 97 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.93574894 |
| 98 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.91670895 |
| 99 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90419254 |
| 100 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.88477522 |
| 101 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.87286174 |
| 102 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87149738 |
| 103 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86202523 |
| 104 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.85580216 |
| 105 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.84417713 |
| 106 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.82877940 |
| 107 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.82770389 |
| 108 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.78842995 |
| 109 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78781580 |
| 110 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.78330392 |
| 111 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.77839365 |
| 112 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76238566 |
| 113 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76235984 |
| 114 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.75499399 |
| 115 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.74031862 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.40585521 |
| 2 | MP0003303_peritoneal_inflammation | 3.53883800 |
| 3 | MP0003436_decreased_susceptibility_to | 3.27463748 |
| 4 | MP0000685_abnormal_immune_system | 3.25972158 |
| 5 | * MP0001800_abnormal_humoral_immune | 3.21311159 |
| 6 | MP0005671_abnormal_response_to | 3.19512567 |
| 7 | MP0001790_abnormal_immune_system | 3.16967894 |
| 8 | MP0005387_immune_system_phenotype | 3.16967894 |
| 9 | MP0009785_altered_susceptibility_to | 3.07171657 |
| 10 | MP0005000_abnormal_immune_tolerance | 3.02777029 |
| 11 | * MP0002452_abnormal_antigen_presenting | 2.92293831 |
| 12 | MP0005025_abnormal_response_to | 2.77664415 |
| 13 | MP0002723_abnormal_immune_serum | 2.77263126 |
| 14 | MP0002419_abnormal_innate_immunity | 2.75493720 |
| 15 | * MP0002420_abnormal_adaptive_immunity | 2.67931858 |
| 16 | * MP0001819_abnormal_immune_cell | 2.66019482 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.50983356 |
| 18 | MP0003763_abnormal_thymus_physiology | 2.44180654 |
| 19 | * MP0002398_abnormal_bone_marrow | 2.41200774 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.38789925 |
| 21 | MP0006082_CNS_inflammation | 2.37773730 |
| 22 | MP0002396_abnormal_hematopoietic_system | 2.30644292 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.22340229 |
| 24 | * MP0000716_abnormal_immune_system | 2.21805630 |
| 25 | MP0002405_respiratory_system_inflammati | 2.20139668 |
| 26 | MP0000689_abnormal_spleen_morphology | 2.11612608 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 2.05114404 |
| 28 | MP0004510_myositis | 2.03406203 |
| 29 | MP0003724_increased_susceptibility_to | 2.02795384 |
| 30 | MP0005058_abnormal_lysosome_morphology | 2.01512398 |
| 31 | MP0002722_abnormal_immune_system | 1.98454579 |
| 32 | MP0002166_altered_tumor_susceptibility | 1.98030294 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.90557445 |
| 34 | MP0009278_abnormal_bone_marrow | 1.89106291 |
| 35 | * MP0002429_abnormal_blood_cell | 1.88365416 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.87668486 |
| 37 | MP0001853_heart_inflammation | 1.87111058 |
| 38 | MP0004947_skin_inflammation | 1.86342565 |
| 39 | MP0004808_abnormal_hematopoietic_stem | 1.82281749 |
| 40 | MP0001873_stomach_inflammation | 1.78038230 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.73267361 |
| 42 | MP0001545_abnormal_hematopoietic_system | 1.73267361 |
| 43 | MP0002006_tumorigenesis | 1.66730652 |
| 44 | MP0008260_abnormal_autophagy | 1.65257721 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.64945936 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.63216174 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.61739879 |
| 48 | MP0000703_abnormal_thymus_morphology | 1.59742529 |
| 49 | MP0008469_abnormal_protein_level | 1.47112597 |
| 50 | MP0005310_abnormal_salivary_gland | 1.42789473 |
| 51 | MP0002933_joint_inflammation | 1.39254514 |
| 52 | MP0005451_abnormal_body_composition | 1.38805621 |
| 53 | MP0003866_abnormal_defecation | 1.35372536 |
| 54 | MP0003191_abnormal_cellular_cholesterol | 1.35342455 |
| 55 | MP0005174_abnormal_tail_pigmentation | 1.34836314 |
| 56 | MP0000490_abnormal_crypts_of | 1.33692543 |
| 57 | MP0003448_altered_tumor_morphology | 1.33625597 |
| 58 | MP0003183_abnormal_peptide_metabolism | 1.28349457 |
| 59 | MP0004381_abnormal_hair_follicle | 1.27859755 |
| 60 | MP0000858_altered_metastatic_potential | 1.22332222 |
| 61 | MP0009840_abnormal_foam_cell | 1.17016498 |
| 62 | MP0010307_abnormal_tumor_latency | 1.16699300 |
| 63 | MP0000343_altered_response_to | 1.14324203 |
| 64 | MP0004883_abnormal_blood_vessel | 1.11589029 |
| 65 | MP0009764_decreased_sensitivity_to | 1.04540129 |
| 66 | MP0001851_eye_inflammation | 1.03531050 |
| 67 | MP0002277_abnormal_respiratory_mucosa | 1.00027470 |
| 68 | MP0002019_abnormal_tumor_incidence | 0.97043490 |
| 69 | MP0003690_abnormal_glial_cell | 0.95664636 |
| 70 | MP0010352_gastrointestinal_tract_polyps | 0.91921870 |
| 71 | MP0003075_altered_response_to | 0.91287762 |
| 72 | MP0002998_abnormal_bone_remodeling | 0.90559168 |
| 73 | MP0005164_abnormal_response_to | 0.84149987 |
| 74 | MP0005166_decreased_susceptibility_to | 0.83224439 |
| 75 | MP0003828_pulmonary_edema | 0.82952596 |
| 76 | MP0005076_abnormal_cell_differentiation | 0.82849899 |
| 77 | MP0000015_abnormal_ear_pigmentation | 0.81537772 |
| 78 | MP0002009_preneoplasia | 0.81383237 |
| 79 | MP0009763_increased_sensitivity_to | 0.79381196 |
| 80 | MP0005075_abnormal_melanosome_morpholog | 0.78945797 |
| 81 | MP0003566_abnormal_cell_adhesion | 0.77319149 |
| 82 | MP0000604_amyloidosis | 0.76568594 |
| 83 | MP0003693_abnormal_embryo_hatching | 0.76362591 |
| 84 | MP0003806_abnormal_nucleotide_metabolis | 0.75937257 |
| 85 | MP0003045_fibrosis | 0.75285969 |
| 86 | MP0003656_abnormal_erythrocyte_physiolo | 0.74761364 |
| 87 | MP0001663_abnormal_digestive_system | 0.72123159 |
| 88 | MP0008004_abnormal_stomach_pH | 0.71244345 |
| 89 | MP0005023_abnormal_wound_healing | 0.70316952 |
| 90 | MP0001986_abnormal_taste_sensitivity | 0.69109293 |
| 91 | MP0003077_abnormal_cell_cycle | 0.67842897 |
| 92 | MP0002095_abnormal_skin_pigmentation | 0.66240954 |
| 93 | MP0000569_abnormal_digit_pigmentation | 0.65911048 |
| 94 | MP0000249_abnormal_blood_vessel | 0.65464217 |
| 95 | MP0005390_skeleton_phenotype | 0.65346197 |
| 96 | MP0010094_abnormal_chromosome_stability | 0.62322657 |
| 97 | MP0002132_abnormal_respiratory_system | 0.61533913 |
| 98 | MP0008874_decreased_physiological_sensi | 0.60954924 |
| 99 | MP0000313_abnormal_cell_death | 0.59992681 |
| 100 | MP0008057_abnormal_DNA_replication | 0.59646701 |
| 101 | MP0003795_abnormal_bone_structure | 0.58533634 |
| 102 | MP0002136_abnormal_kidney_physiology | 0.57963956 |
| 103 | MP0008873_increased_physiological_sensi | 0.57469431 |
| 104 | MP0006054_spinal_hemorrhage | 0.53446083 |
| 105 | MP0000609_abnormal_liver_physiology | 0.52628873 |
| 106 | MP0000371_diluted_coat_color | 0.51618142 |
| 107 | MP0002138_abnormal_hepatobiliary_system | 0.51273702 |
| 108 | MP0008007_abnormal_cellular_replicative | 0.50389705 |
| 109 | MP0000598_abnormal_liver_morphology | 0.49762292 |
| 110 | MP0003221_abnormal_cardiomyocyte_apopto | 0.49148559 |
| 111 | MP0003091_abnormal_cell_migration | 0.48710394 |
| 112 | MP0002693_abnormal_pancreas_physiology | 0.48640663 |
| 113 | MP0003453_abnormal_keratinocyte_physiol | 0.47316676 |
| 114 | MP0000477_abnormal_intestine_morphology | 0.45782141 |
| 115 | MP0009765_abnormal_xenobiotic_induced | 0.45064717 |
| 116 | MP0005319_abnormal_enzyme/_coenzyme | 0.44296764 |
| 117 | MP0005167_abnormal_blood-brain_barrier | 0.44185363 |
| 118 | MP0004130_abnormal_muscle_cell | 0.43254033 |
| 119 | MP0000920_abnormal_myelination | 0.42573217 |
| 120 | MP0005381_digestive/alimentary_phenotyp | 0.42448472 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.99951569 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.60722915 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.30958540 |
| 4 | Chronic otitis media (HP:0000389) | 4.48761080 |
| 5 | Recurrent viral infections (HP:0004429) | 4.46094214 |
| 6 | IgM deficiency (HP:0002850) | 4.43217255 |
| 7 | Recurrent fungal infections (HP:0002841) | 4.35085995 |
| 8 | Myositis (HP:0100614) | 4.33991671 |
| 9 | Cellulitis (HP:0100658) | 4.22235422 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.17198899 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.13880473 |
| 12 | Abnormality of macrophages (HP:0004311) | 3.94604082 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 3.91289479 |
| 14 | Meningitis (HP:0001287) | 3.90442643 |
| 15 | Recurrent bronchitis (HP:0002837) | 3.89121134 |
| 16 | Gastrointestinal infarctions (HP:0005244) | 3.82927200 |
| 17 | Chronic obstructive pulmonary disease (HP:0006510) | 3.75074591 |
| 18 | Obstructive lung disease (HP:0006536) | 3.75074591 |
| 19 | Recurrent skin infections (HP:0001581) | 3.74470002 |
| 20 | Agammaglobulinemia (HP:0004432) | 3.72390422 |
| 21 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.65803872 |
| 22 | Inflammation of the large intestine (HP:0002037) | 3.55576729 |
| 23 | Panhypogammaglobulinemia (HP:0003139) | 3.49610272 |
| 24 | Gastrointestinal inflammation (HP:0004386) | 3.47300170 |
| 25 | Vasculitis (HP:0002633) | 3.37386521 |
| 26 | Colitis (HP:0002583) | 3.37197101 |
| 27 | Nasal polyposis (HP:0100582) | 3.34123762 |
| 28 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.30540080 |
| 29 | Recurrent cutaneous fungal infections (HP:0011370) | 3.30540080 |
| 30 | Orchitis (HP:0100796) | 3.21670350 |
| 31 | Keratoconjunctivitis (HP:0001096) | 3.20897404 |
| 32 | Stomatitis (HP:0010280) | 3.20613734 |
| 33 | Spontaneous hematomas (HP:0007420) | 3.16291765 |
| 34 | Autoimmune thrombocytopenia (HP:0001973) | 3.14033060 |
| 35 | T lymphocytopenia (HP:0005403) | 3.11778991 |
| 36 | Pustule (HP:0200039) | 3.11393973 |
| 37 | Abnormality of T cells (HP:0002843) | 3.10964488 |
| 38 | Abnormality of the nasal mucosa (HP:0000433) | 3.10496552 |
| 39 | Thrombocytosis (HP:0001894) | 3.09282014 |
| 40 | Optic neuritis (HP:0100653) | 3.08165084 |
| 41 | Retrobulbar optic neuritis (HP:0100654) | 3.08165084 |
| 42 | Abnormality of T cell number (HP:0011839) | 3.04981734 |
| 43 | Vacuolated lymphocytes (HP:0001922) | 3.04397230 |
| 44 | Increased cerebral lipofuscin (HP:0011813) | 2.99468900 |
| 45 | Abnormality of T cell physiology (HP:0011840) | 2.95050622 |
| 46 | Interstitial pulmonary disease (HP:0006530) | 2.94728560 |
| 47 | Increased IgM level (HP:0003496) | 2.93538321 |
| 48 | Lymphopenia (HP:0001888) | 2.91286614 |
| 49 | Petechiae (HP:0000967) | 2.90129253 |
| 50 | Osteomyelitis (HP:0002754) | 2.89874989 |
| 51 | Gastrointestinal stroma tumor (HP:0100723) | 2.84851783 |
| 52 | Gingivitis (HP:0000230) | 2.84673607 |
| 53 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.83990818 |
| 54 | B lymphocytopenia (HP:0010976) | 2.83382113 |
| 55 | Abnormality of B cell number (HP:0010975) | 2.83382113 |
| 56 | Papilloma (HP:0012740) | 2.71512281 |
| 57 | Verrucae (HP:0200043) | 2.71512281 |
| 58 | Thyroiditis (HP:0100646) | 2.70147778 |
| 59 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.69628919 |
| 60 | Systemic lupus erythematosus (HP:0002725) | 2.68568853 |
| 61 | Prolonged bleeding time (HP:0003010) | 2.67851010 |
| 62 | Autoimmune hemolytic anemia (HP:0001890) | 2.65718446 |
| 63 | Chronic sinusitis (HP:0011109) | 2.63503024 |
| 64 | Recurrent sinusitis (HP:0011108) | 2.61460010 |
| 65 | Pulmonary embolism (HP:0002204) | 2.60885667 |
| 66 | Increased IgE level (HP:0003212) | 2.59338555 |
| 67 | Leukocytosis (HP:0001974) | 2.58332551 |
| 68 | Recurrent pneumonia (HP:0006532) | 2.58081856 |
| 69 | Pulmonary infiltrates (HP:0002113) | 2.53868106 |
| 70 | Eosinophilia (HP:0001880) | 2.52719954 |
| 71 | Arterial thrombosis (HP:0004420) | 2.51289613 |
| 72 | Encephalitis (HP:0002383) | 2.50886667 |
| 73 | Hypochromic anemia (HP:0001931) | 2.50854846 |
| 74 | IgG deficiency (HP:0004315) | 2.47481367 |
| 75 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.45472217 |
| 76 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.45472217 |
| 77 | Abnormality of glycolipid metabolism (HP:0010969) | 2.45472217 |
| 78 | Recurrent lower respiratory tract infections (HP:0002783) | 2.44486093 |
| 79 | Periodontitis (HP:0000704) | 2.43955478 |
| 80 | Urticaria (HP:0001025) | 2.43122445 |
| 81 | Anorexia (HP:0002039) | 2.42876504 |
| 82 | Epistaxis (HP:0000421) | 2.41742694 |
| 83 | IgA deficiency (HP:0002720) | 2.38608574 |
| 84 | Hypochromic microcytic anemia (HP:0004840) | 2.38214858 |
| 85 | Dysostosis multiplex (HP:0000943) | 2.37650461 |
| 86 | Gangrene (HP:0100758) | 2.37084161 |
| 87 | Abnormality of the pleura (HP:0002103) | 2.36956821 |
| 88 | Episodic fever (HP:0001954) | 2.35118290 |
| 89 | Hematochezia (HP:0002573) | 2.34797272 |
| 90 | Hemoptysis (HP:0002105) | 2.33375052 |
| 91 | Emphysema (HP:0002097) | 2.33015007 |
| 92 | Granulocytopenia (HP:0001913) | 2.32662012 |
| 93 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.29964455 |
| 94 | Gingival bleeding (HP:0000225) | 2.29846507 |
| 95 | Sepsis (HP:0100806) | 2.27112351 |
| 96 | Chest pain (HP:0100749) | 2.26217279 |
| 97 | Impaired platelet aggregation (HP:0003540) | 2.22093353 |
| 98 | Abnormal platelet function (HP:0011869) | 2.22093353 |
| 99 | Skin ulcer (HP:0200042) | 2.21819295 |
| 100 | Lymphoma (HP:0002665) | 2.19874028 |
| 101 | Abnormality of eosinophils (HP:0001879) | 2.18665486 |
| 102 | Abnormality of the prostate (HP:0008775) | 2.17896273 |
| 103 | Chronic diarrhea (HP:0002028) | 2.15450733 |
| 104 | Combined immunodeficiency (HP:0005387) | 2.13449612 |
| 105 | Viral hepatitis (HP:0006562) | 2.13046133 |
| 106 | Keratoconjunctivitis sicca (HP:0001097) | 2.12582529 |
| 107 | Purpura (HP:0000979) | 2.12549328 |
| 108 | Severe combined immunodeficiency (HP:0004430) | 2.12079104 |
| 109 | Amyloidosis (HP:0011034) | 2.11333306 |
| 110 | Glomerulopathy (HP:0100820) | 2.10814871 |
| 111 | Hypergammaglobulinemia (HP:0010702) | 2.07838104 |
| 112 | Loss of speech (HP:0002371) | 2.07826220 |
| 113 | Hepatosplenomegaly (HP:0001433) | 2.07319156 |
| 114 | Bronchitis (HP:0012387) | 2.06759086 |
| 115 | Microcytic anemia (HP:0001935) | 2.06632701 |
| 116 | Disinhibition (HP:0000734) | 2.05645297 |
| 117 | Abnormality of the fingertips (HP:0001211) | 2.04591095 |
| 118 | Abnormality of the peritoneum (HP:0002585) | 2.03261786 |
| 119 | Skin rash (HP:0000988) | 2.02945692 |
| 120 | Restrictive lung disease (HP:0002091) | 2.02481856 |
| 121 | Agnosia (HP:0010524) | 2.00348545 |
| 122 | Slow saccadic eye movements (HP:0000514) | 1.99736567 |
| 123 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.98223969 |
| 124 | Increased serum ferritin (HP:0003281) | 1.98172102 |
| 125 | Basal ganglia calcification (HP:0002135) | 1.97691714 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.26768213 |
| 2 | BLK | 3.07454686 |
| 3 | KIT | 2.72927326 |
| 4 | TYK2 | 2.71966756 |
| 5 | TXK | 2.62009837 |
| 6 | TBK1 | 2.52475764 |
| 7 | JAK3 | 2.41675196 |
| 8 | PRPF4B | 2.39646154 |
| 9 | IRAK4 | 2.38244894 |
| 10 | BTK | 2.32339682 |
| 11 | ZAP70 | 2.23845160 |
| 12 | EEF2K | 2.22748405 |
| 13 | MAP3K14 | 2.16351157 |
| 14 | STK10 | 2.13856195 |
| 15 | RIPK4 | 2.09514359 |
| 16 | ERN1 | 2.06296961 |
| 17 | MAP3K10 | 1.95686030 |
| 18 | IKBKE | 1.94302634 |
| 19 | GRK6 | 1.93400286 |
| 20 | * SYK | 1.89199681 |
| 21 | TGFBR2 | 1.82140408 |
| 22 | TEC | 1.74575937 |
| 23 | JAK1 | 1.71976935 |
| 24 | * FES | 1.66248547 |
| 25 | HCK | 1.63807821 |
| 26 | ITK | 1.60135851 |
| 27 | CSK | 1.59248280 |
| 28 | IKBKB | 1.56985501 |
| 29 | LRRK2 | 1.56942949 |
| 30 | PKN2 | 1.56543779 |
| 31 | IRAK3 | 1.55470404 |
| 32 | NME2 | 1.53191367 |
| 33 | LCK | 1.49817362 |
| 34 | EPHB1 | 1.41063180 |
| 35 | TRIB3 | 1.40933877 |
| 36 | CLK1 | 1.38368175 |
| 37 | SIK2 | 1.31551514 |
| 38 | MAP2K3 | 1.30288587 |
| 39 | BMPR2 | 1.24671978 |
| 40 | * LYN | 1.24416842 |
| 41 | * CSF1R | 1.24390777 |
| 42 | MAP3K13 | 1.23585606 |
| 43 | TAOK1 | 1.23465856 |
| 44 | TAOK3 | 1.21477247 |
| 45 | PIM1 | 1.19895877 |
| 46 | FGFR4 | 1.19451421 |
| 47 | RPS6KA4 | 1.14785577 |
| 48 | FLT3 | 1.10915525 |
| 49 | MAP3K1 | 1.06921187 |
| 50 | FGFR3 | 1.01759515 |
| 51 | PIM2 | 0.96516639 |
| 52 | MARK3 | 0.96478070 |
| 53 | JAK2 | 0.92859279 |
| 54 | TAOK2 | 0.85372673 |
| 55 | TESK2 | 0.84603571 |
| 56 | IRAK1 | 0.82317779 |
| 57 | KDR | 0.79360380 |
| 58 | CHUK | 0.78890238 |
| 59 | NEK2 | 0.78334218 |
| 60 | YES1 | 0.77880614 |
| 61 | KSR2 | 0.77677676 |
| 62 | MATK | 0.77336944 |
| 63 | NLK | 0.77115816 |
| 64 | CDK4 | 0.76956445 |
| 65 | TNK2 | 0.76529873 |
| 66 | TGFBR1 | 0.76426801 |
| 67 | CAMKK2 | 0.72346790 |
| 68 | STK4 | 0.71719248 |
| 69 | MARK2 | 0.69949459 |
| 70 | PIK3CG | 0.69860641 |
| 71 | SMG1 | 0.69726522 |
| 72 | GRK7 | 0.69151593 |
| 73 | SCYL2 | 0.68437647 |
| 74 | PTK6 | 0.66858854 |
| 75 | ALK | 0.65031953 |
| 76 | CDC42BPA | 0.63961961 |
| 77 | IRAK2 | 0.63668468 |
| 78 | CDK19 | 0.61858095 |
| 79 | PRKCQ | 0.61665246 |
| 80 | MAPK7 | 0.61306608 |
| 81 | PDPK1 | 0.60319036 |
| 82 | CDK12 | 0.59587374 |
| 83 | MAPK4 | 0.59024688 |
| 84 | TRPM7 | 0.58128848 |
| 85 | CAMKK1 | 0.56262197 |
| 86 | MST4 | 0.55439921 |
| 87 | MAP3K8 | 0.53944820 |
| 88 | NEK9 | 0.53350665 |
| 89 | TTN | 0.53262340 |
| 90 | SIK3 | 0.53192510 |
| 91 | * FGR | 0.52385333 |
| 92 | PRKD2 | 0.51626396 |
| 93 | PRKCH | 0.51364546 |
| 94 | MAP3K11 | 0.49457941 |
| 95 | PAK4 | 0.49291548 |
| 96 | PDK1 | 0.49041645 |
| 97 | CDK6 | 0.48842590 |
| 98 | RPS6KA6 | 0.48152619 |
| 99 | CAMK1D | 0.47532143 |
| 100 | ABL1 | 0.47227038 |
| 101 | MAP3K5 | 0.47025077 |
| 102 | HIPK2 | 0.45565757 |
| 103 | MAPKAPK2 | 0.44634492 |
| 104 | MAP2K6 | 0.43735643 |
| 105 | MAPK11 | 0.42693962 |
| 106 | RPS6KB2 | 0.39755974 |
| 107 | PRKCD | 0.38999006 |
| 108 | PTK2B | 0.36161253 |
| 109 | RPS6KC1 | 0.35338306 |
| 110 | RPS6KL1 | 0.35338306 |
| 111 | EPHA3 | 0.33427020 |
| 112 | STK11 | 0.33285511 |
| 113 | MAP2K2 | 0.32981771 |
| 114 | MAP3K6 | 0.32258687 |
| 115 | DYRK1B | 0.31908111 |
| 116 | FYN | 0.31432164 |
| 117 | MAP3K3 | 0.30409254 |
| 118 | * EGFR | 0.30385267 |
| 119 | RET | 0.29640328 |
| 120 | STK24 | 0.27772141 |
| 121 | ACVR1B | 0.26908117 |
| 122 | SGK3 | 0.26661062 |
| 123 | ATR | 0.26387741 |
| 124 | EIF2AK3 | 0.26318444 |
| 125 | CDC7 | 0.26195234 |
| 126 | RAF1 | 0.25082546 |
| 127 | MAPK3 | 0.24382744 |
| 128 | MAP3K7 | 0.24360863 |
| 129 | MAPK12 | 0.24288710 |
| 130 | RPS6KA5 | 0.22756397 |
| 131 | CAMK1G | 0.21449266 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.47952702 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.10374642 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.99726043 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.57320118 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.53545671 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.29043639 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.28490098 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.26319666 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.23545994 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.17897455 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.14658105 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.08384821 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.05394947 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.96609083 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.81394316 |
| 16 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.81126766 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.75837794 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.75629163 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 1.75376856 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 1.74984400 |
| 21 | Pertussis_Homo sapiens_hsa05133 | 1.73182809 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.68861025 |
| 23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.66211198 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.65675151 |
| 25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.65202326 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.62112689 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.56631864 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.53413286 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53406365 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.51395799 |
| 31 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.47922713 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.44538391 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.43583566 |
| 34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.39835459 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.36382720 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.35467844 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.34416204 |
| 38 | DNA replication_Homo sapiens_hsa03030 | 1.32801024 |
| 39 | * Shigellosis_Homo sapiens_hsa05131 | 1.32496751 |
| 40 | Asthma_Homo sapiens_hsa05310 | 1.31915206 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28828860 |
| 42 | Lysosome_Homo sapiens_hsa04142 | 1.24877875 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 1.22297481 |
| 44 | Viral myocarditis_Homo sapiens_hsa05416 | 1.17469026 |
| 45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.13799298 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 1.07225859 |
| 47 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.06211234 |
| 48 | Ribosome_Homo sapiens_hsa03010 | 1.05388954 |
| 49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.01677316 |
| 50 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.00264159 |
| 51 | Base excision repair_Homo sapiens_hsa03410 | 0.98317328 |
| 52 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.98310708 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.95945665 |
| 54 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.92814396 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90245764 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 0.88218919 |
| 57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.87458631 |
| 58 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.86925128 |
| 59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.85255245 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.83663003 |
| 61 | Phagosome_Homo sapiens_hsa04145 | 0.82436081 |
| 62 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.82350556 |
| 63 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75702159 |
| 64 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.75227381 |
| 65 | HTLV-I infection_Homo sapiens_hsa05166 | 0.73645136 |
| 66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.73432422 |
| 67 | Mismatch repair_Homo sapiens_hsa03430 | 0.72410465 |
| 68 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.71425851 |
| 69 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.69602886 |
| 70 | * Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.69201872 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67401834 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.65080752 |
| 73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60940095 |
| 74 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.57073909 |
| 75 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.56021736 |
| 76 | Colorectal cancer_Homo sapiens_hsa05210 | 0.53822306 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53064469 |
| 78 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52351580 |
| 79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50969463 |
| 80 | Spliceosome_Homo sapiens_hsa03040 | 0.48306136 |
| 81 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47671124 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47253351 |
| 83 | Endocytosis_Homo sapiens_hsa04144 | 0.46189717 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45422366 |
| 85 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.42849472 |
| 86 | Homologous recombination_Homo sapiens_hsa03440 | 0.42079229 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40902717 |
| 88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38414420 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | 0.38367470 |
| 90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38353724 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38065974 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37069838 |
| 93 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.36582004 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.34769700 |
| 95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34497880 |
| 96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33664707 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.32423374 |
| 98 | Endometrial cancer_Homo sapiens_hsa05213 | 0.32173572 |
| 99 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.28678069 |
| 100 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.27813424 |
| 101 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.27005776 |
| 102 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.26976115 |
| 103 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.26754062 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26620759 |
| 105 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.26532819 |
| 106 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26386459 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.26207356 |
| 108 | Cell cycle_Homo sapiens_hsa04110 | 0.24624028 |
| 109 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24433227 |
| 110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.21699302 |
| 111 | Prostate cancer_Homo sapiens_hsa05215 | 0.21099337 |
| 112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.20785262 |
| 113 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.20748048 |
| 114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.19898519 |
| 115 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.19740912 |
| 116 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.18017050 |
| 117 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.17899965 |

